C20orf203

Model summary

A soluble nucleocytoplasmic adaptor that uses multivalent protein binding to coordinate transport and quality-control pathways. By assembling cargo with nuclear import machinery, it promotes regulated entry into the nucleus, while buffering cytosolic substrates from autophagic and proteasomal routes. This scaffolding role stabilizes selected proteins, suppresses autophagy, and dampens ubiquitin-mediated degradation, thereby tuning broader protein metabolic programs across the cytosol and nucleoplasm.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture: the polypeptide is entirely encompassed by IPR040965 (Protein of unknown function DUF5559 family) spanning residues 1–194.

   A single, full-length DUF family signature without catalytic motifs or transmembrane segments indicates a soluble adaptor/scaffold rather than an enzyme or transporter. Such architectures typically mediate selective macromolecular interactions through low-complexity or coiled interfaces, which causally supports a primary molecular role in protein binding (GO:0005515).

2. 02

   From this scaffold-like foundation, I infer function by mapping the biological processes that this architecture can enable.

   The absence of enzymatic cores and the presence of nucleocytoplasmic shuttling signals point toward regulated assembly and trafficking of protein complexes. This adaptor capacity explains several transport and quality-control axes:

3. 03

   1.

   Protein import into nucleus (GO:0006606): A soluble adaptor can chaperone or present cargo to nuclear import machinery, biasing nucleocytoplasmic partitioning and thereby tuning transcriptional and stress-response programs. 2. Intracellular protein transport (GO:0006886): A non-enzymatic binder can couple cargo to trafficking pathways and timing checkpoints that distribute proteins between cytosol and nucleus. 3. Negative regulation of autophagy (GO:0010507): By sequestering or shielding specific substrates from autophagic capture, a binding scaffold can suppress autophagic flux—either by stabilizing targets or by diverting them from autophagosome pathways. 4. Negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435): A binding platform can occlude ubiquitin-accessible surfaces, compete for E3/E2 assemblies, or stabilize folded states, thereby reducing proteasomal delivery of select substrates. 5. Regulation of protein metabolic process (GO:0051248): Coordinating transport and degradation pathways places this adaptor squarely in the control of protein homeostasis.

4. 04

   Cellular localization follows directly from these operations.

   The soluble, non-membranous architecture and nucleocytoplasmic shuttling behavior place the protein in the cytosol (GO:0005829) and nucleoplasm (GO:0005654). This dual residency allows it to assemble cargo in the cytosol and modulate nuclear entry and function.

5. 05

   Mechanistically, I propose that the DUF5559 scaffold forms transient complexes that gate substrate fate at the cytosol–nucleus interface.

   By binding client proteins and import adaptors, it promotes nuclear import while simultaneously buffering cytosolic pools from autophagic and proteasomal routes. This buffering would manifest as reduced autophagic capture and dampened ubiquitin-mediated turnover of specific targets.

6. 06

   From this model, likely interaction partners include nuclear transport receptors and adaptors (importin-β/KPNB1, importin-α family, and transportin/TNPO1) that drive nucleocytoplasmic exchange; autophagy initiators and elongators (ATG5–ATG12–ATG16L1 complex and LC3/GABARAPs) that determine autophagic entry; and proteasome-associated shuttles and receptors (RAD23A/B, UBQLN family, and the 19S regulatory particle) that specify proteasomal delivery.

   Together, these hypothesized contacts provide the physical basis for the observed transport, autophagy suppression, and proteasome modulation within a soluble nucleocytoplasmic adaptor framework.